Crescent Biopharma, Inc. - Common Stock (NQ:CBIO)

14.72 +0.25 (+1.76%)

Streaming Delayed Price Updated: 2:53 PM EDT, Aug 3, 2026 Add to My Watchlist

Price and Volume

Volume	116,516
Open	14.82
Bid (Size)	14.68 (100)
Ask (Size)	14.77 (100)
Prev. Close	14.47
Today's Range	14.00 - 14.90
52wk Range	8.720 - 27.41
Shares Outstanding	64,532,091
Dividend Yield	3.26%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Crescent Biopharma Announces Grants of Inducement Awards

Today 7:30 EDT

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

July 30, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Performance

YTD	+32.9%	+32.9%
1 Month	-13.2%	-13.2%
3 Month	-17.8%	-17.8%
6 Month	+49.9%	+49.9%
1 Year	+24.4%	+24.4%

More News

Crescent Biopharma Announces Grants of Inducement Awards

July 23, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

July 16, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

July 14, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

July 14, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

June 26, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

June 11, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma to Present at June Investor Conferences

June 02, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

May 29, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

May 21, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

May 12, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma to Present at May Investor Conferences

May 06, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Which stocks are moving on Friday? ↗

May 01, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

May 01, 2026

Via Chartmill

Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights

April 29, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

April 24, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

March 27, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

March 06, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

February 26, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma to Present at March Investor Conferences

February 23, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

February 19, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors

February 18, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

February 05, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards

January 30, 2026

From Crescent Biopharma, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Crescent Biopharma, Inc. - Common Stock publicly traded?

Yes, Crescent Biopharma, Inc. - Common Stock is publicly traded.

What exchange does Crescent Biopharma, Inc. - Common Stock trade on?

Crescent Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Crescent Biopharma, Inc. - Common Stock?

The ticker symbol for Crescent Biopharma, Inc. - Common Stock is CBIO on the Nasdaq Stock Market

What is the current price of Crescent Biopharma, Inc. - Common Stock?

The current price of Crescent Biopharma, Inc. - Common Stock is 14.72

When was Crescent Biopharma, Inc. - Common Stock last traded?

The last trade of Crescent Biopharma, Inc. - Common Stock was at 08/03/26 02:53 PM ET

What is the market capitalization of Crescent Biopharma, Inc. - Common Stock?

The market capitalization of Crescent Biopharma, Inc. - Common Stock is 950.24M

How many shares of Crescent Biopharma, Inc. - Common Stock are outstanding?

Crescent Biopharma, Inc. - Common Stock has 950M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.